TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M) (“Maricann” or “The Company”), is pleased to welcome Geoff Kosar to the team. Geoff is joining Maricann in the role of Vice President, Sales & Marketing and will provide leadership to all commercial activities with a focus on the recreational aspect of the business – if, and when legalized.
Geoff brings with him a wealth of experience. Most recently he was Head of Marketing at one of the largest spirits companies in Canada. Geoff spent 8 years in that role and during that time provided guidance to brand development and market penetration strategies for many leading spirit & beer brands.
Geoff has demonstrated a record of success as acting Business Unit Director and Category Manager for wines with the Liquor Control Board of Ontario (LCBO). Strong leadership in brand strategy development, digital marketing, and relationship management are key strengths that Geoff brings to Maricann.
“Geoff’s demonstrated leadership at one of Canada’s largest spirits companies, specifically in brand development and line extensions within product categories, will ensure Maricann is well positioned in the Canadian recreational market.”
– Ben Ward, Maricann CEO
“I look forward to build on Maricann’s success, to establish Maricann as a leader in the recreational market.”
– Geoff Kosar, Maricann VP Sales & Marketing
About Maricann Group Inc.
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario, Canada where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada, and Dresden, Saxony, Germany. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, capable of producing 95,000 kg of dry cannabis flower per year to support existing and future patient growth.
For more information about Maricann, please visit our website at www.maricann.com
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Forward Looking Information
Certain statements in this press release contain forward-looking statements, including with respect to the Company’s positioning in the recreational cannabis market and future production capacity, which can be identified by the use of forward-looking terminology such as “believes”, “expects”, “may”, “desires”, “will”, “should”, “projects”, “estimates”, “contemplates”, “anticipates”, “intends”, or any negative such as “does not believe” or other variations thereof or comparable terminology. No assurance can be given that potential future results or circumstances described in the forward-looking statements will be achieved or will occur. By their nature, these forward-looking statements, necessarily involve risks and uncertainties, including those discussed herein, that could cause actual results to significantly differ from those contemplated by these forward-looking statements. Such statements reflect the view of the Company with respect to future events, and are based on information currently available to the Company and on assumptions, which it considers reasonable. Management cautions readers that the assumptions relative to the future events, several of which are beyond Management’s control, could prove to be incorrect, given that they are subject to certain risk and uncertainties, and that actual results may differ materially from those projected. Factors which could cause results or events to differ from current expectations include, among other things: uncertainties with respect to legalization of recreational cannabis; risks inherent to expansion project; fluctuations in operating results; the impact of general economic, industry and market conditions; the ability to recruit and retain qualified employees; fluctuations in cash flow; increased levels of outstanding debt and obligations under a capital lease; expectations regarding market demand for particular products and the dependence on new product development; the impact of market change; and the impact of price and product competition, as well as other risks discussed in its latest annual information form and other disclosure documents of the Company available at www.sedar.com. Management disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking information.
CONTACT INFORMATION
Contact information:
Investor Relations:
Graham Farrell
Director of Investor Relations
[email protected]
647-643-7665
Corporate Headquarters (Canada)
Maricann Group Inc. (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3
Canada
289-288-6274
European Headquarters (Germany)
Maricann GmbH
Thierschstrasse 3, 80538 Munchen, Deutschland